HWP
REGN icon

Highline Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Highline Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Sell
20
-3
-13% -$2.04K ﹤0.01% 505
2026
Q1 		$17.8K Buy
23
+8
+53% +$6.13K ﹤0.01% 320
2025
Q4 		$11.6K Buy
15
+10
+200% +$6.79K ﹤0.01% 368
2025
Q3 		$2.82K Buy
5
+1
+25% +$565 ﹤0.01% 775
2025
Q2 		$2.1K Sell
4
-5
-56% -$2.79K ﹤0.01% 637
2025
Q1 		$5.71K Buy
9
+3
+50% +$2.06K ﹤0.01% 400
2024
Q4 		$4.27K Buy
6
+3
+100% +$2.52K ﹤0.01% 367
2024
Q3 		$3.15K Buy
3
+1
+50% +$1.11K ﹤0.01% 404
2024
Q2 		$2.1K Hold
2
– – ﹤0.01% 393
2024
Q1 		$1.93K Hold
2
– – ﹤0.01% 334
2023
Q4 		$1.76K Hold
2
– – ﹤0.01% 307
2023
Q3 		$1.65K Hold
2
– – ﹤0.01% 283
2023
Q2 		$1.44K Hold
2
– – ﹤0.01% 248
2023
Q1 		$1.64K Hold
2
– – ﹤0.01% 241
2022
Q4 		$1.44K Hold
2
– – ﹤0.01% 246
2022
Q3 		$1.38K Buy
+2
New +$1.26K ﹤0.01% 238

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Highline Wealth Partners's REGN Position: Q2 2026 in Review

Highline Wealth Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, selling an estimated $2.04K and leaving 20 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

Highline Wealth Partners first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.8K in Q1 2026. 293 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Highline Wealth Partners held 20 shares of Regeneron Pharmaceuticals worth $12.5K as of Q2 2026.
  • Highline Wealth Partners sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #505 holding.
  • Highline Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's Regeneron Pharmaceuticals position peaked at $17.8K in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.